Legal Representation
Attorney
Lisa M. Tittemore
USPTO Deadlines
Next Deadline
142 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
December 04, 2025
Extension Available
Until June 04, 2025
Application History
35 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 12, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 11, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 11, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 6, 2025 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Jun 6, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 6, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 6, 2025 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Jun 6, 2025 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Jun 6, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 6, 2025 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Jun 3, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 3, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 3, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 3, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 3, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 26, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 26, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jun 26, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 26, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 26, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 26, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Jun 4, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 9, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 9, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 20, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 5, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 4, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 4, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 4, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 8, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 8, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 8, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 8, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 30, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 14, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
House mark for pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology and other related diseases; House mark for pharmaceutical and medical therapeutics for the treatment of oncology, autoimmune, immune-oncology and other related diseases; House mark for diagnostic reagents for the treatment of oncology, autoimmune, immune-oncology and other related diseases
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"